Cleared Traditional

K191550 - Broncholab

K191550 is an FDA 510(k) clearance for Broncholab, manufactured by Fluidda, Inc.. The device is a Class 2 Radiology device with product code JAK cleared through the Traditional 510(k) pathway after a 266-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2020
Decision
266d
Days
Class 2
Risk

K191550 is an FDA 510(k) clearance for the Broncholab. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Fluidda, Inc. (West Hollywood, US). The FDA issued a Cleared decision on March 4, 2020 after a review of 266 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fluidda, Inc. devices

FDA 510(k) Submission Details - K191550

510(k) Number K191550 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2019
Decision Date March 04, 2020
Days to Decision 266 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 107d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAK Device Classification - Class 2, Special Controls

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 717
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K191550.
Hepatic VCAR
K193281 · GE Medical Systems SCS · Mar 2020
Al-Rad Companion (Musculoskeletal)
K193267 · Siemens Medical Solutions USA, Inc. · Mar 2020
CURA 778
K192590 · Fmi Medical Systems, Inc. · Mar 2020
uCT 530, uCT 550
K200016 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2020
Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i
K192832 · Canon Medical Systems Corporation · Feb 2020
Aquilion ONE (TSX-306A/3) V10.0 with Spectral Imaging System
K192828 · Canon Medical Systems Corporation · Feb 2020